SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Excipact scheme to launch next week

By Gareth Macdonald , 17-Jan-2012
Last updated on 17-Jan-2012 at 11:16 GMT

Excipact scheme to launch next week
Excipact scheme to launch next week
Loading...

Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week.

The scheme - known as Excipact - will be unveiled at the International Pharmaceutical Excipients Council Europe’s (IPEC - Europe) 20th anniversary celebrations in Barcelona, Spain on January 25, 2012 by representatives of the IPEC, IPEC-Americas, the EFCG, the FECC and the PQD.

Project director Ian Moore, a QA specialist at specialty chemicals firm Croda, told in-Pharmatechnologist.com that Excipact was created to improve the quality of drug excipients in a way that minimizes supply chain costs for stakeholders.

"The development of Excipact followed the process used by IPEC in the development of its guides," he said, explaining that an expert committee drafted the standards which were then peered-reviewed by organisations involved in the scheme before being put before manufactureres, suppliers and users for consultation.

"The feedback was very positive and constructive with no-one coming back and indicating that the draft was unacceptable," Moore continued adding that "we have also had some feedback from regulatory authorities in Europe and the US which again has been very encouraging."

Industry savings

Moore also set out how excipient suppliers and their drug industry customers that join the scheme stand to benefit in terms of both cost and quality.

For a very modest investment – we expect Excipact certification will cost between €15K and €20K over a three-year audit cycle – they could easily gain between 100 and 200 man days that they would otherwise have spent being audited.”

Excipact uses ISO 9001 as a framework and consists of two annexes covering good manufacturing and distribution practice (GMP/GDP) that can be used to assess excipient suppliers and distributors.

In addition it also covers the competency and quality requirements for third party auditors, based on ISO guidelines 19011 and 17021.

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

John Giannone - incoming IPEC-Americas chairman

Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

Walter Dissinger

President , BASF nutrition and health

Optimism is returning to the pharma fine chemicals sector, says analyst

Optimism is returning to the pharma fine chemicals sector, says analyst

Jan Ramakers

Industry consultant, Jan Ramakers Fine Chemical Consulting Group

Capsugel expands liquid fill capsule capabilities

Keith Hutchison,

Senior VP of research and development (R&D) , Capsugel

New filtration tech boosts biomanufacturing yields, says Sartorius

New filtration tech boosts biomanufacturing yields, says Sartorius

Jens Meyer

Product manager for filtration technologies, Sartorius Stedim

Submit good REMS proposals for FDA brownie points, says RAPS author

Submit good REMS proposals for FDA brownie points, says RAPS author

Ed Tabor

VP of strategic drug development , Quintiles

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Missy Lowery

Marketing Manager for the Americas, Capsugel

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Cory Stevenson & Brandon Pence

Thermo Fisher Scientific

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

Eric Isberg

Global Product Manager, ATMI

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Key Industry Events

 

Access all events listing

Our events, Events from partners...